Literature DB >> 26195574

The Lymphatic Malformation Function (LMF) Instrument.

Erin M Kirkham1, Todd C Edwards2, Edward M Weaver3, Karthik Balakrishnan4, Jonathan A Perkins5.   

Abstract

OBJECTIVE: The Lymphatic Malformation Function (LMF) instrument is a preliminary parent-report assessment designed to measure outcomes in children with cervicofacial lymphatic malformation (LM). This study aimed to assess the measurement properties of the LMF, refine it, test criterion validity, and evaluate the test-retest reliability. STUDY
DESIGN: Cross-sectional.
SETTING: Two pediatric tertiary referral centers.
SUBJECTS: Parents of 60 children from 6 months to 15 years old with cervicofacial LM.
METHODS: Parents were recruited via mail and online. The LMF was administered on paper or online initially and again within 21 days. Response distributions and interitem correlations were examined for item reduction. Exploratory factor analysis was conducted on retained items. Cronbach's α, Spearman correlation, and intraclass correlation (ICC) coefficients were calculated to test internal consistency, criterion validity (compared to stage), and test-retest reliability, respectively.
RESULTS: One item was removed due to a floor effect. The response scale was collapsed from a 5-point scale to a 3-point scale due to skewness. Six items were discarded due to redundancy (interitem correlations >0.7); 2 items were discarded due to factor loadings <0.4. Exploratory factor analysis revealed a 2-factor structure explaining 84% of variance, and the domains Signs and Impacts had good internal consistency (all Cronbach's α >0.80 and <0.90), significant association with stage (P < .05), and good overall test-retest reliability (ICC, 0.82).
CONCLUSION: The LMF has been refined into a 12-item, 2-domain instrument measuring LM-specific signs and impacts with internal consistency, criterion validity, and test-retest reliability. © American Academy of Otolaryngology-Head and Neck Surgery Foundation 2015.

Entities:  

Keywords:  child; disease specific; factor analysis; function; lymphatic malformation; parent-report; pediatric; proxy; quality of life; test-retest reliability; validation

Mesh:

Year:  2015        PMID: 26195574      PMCID: PMC5938064          DOI: 10.1177/0194599815594776

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  13 in total

1.  Quality criteria were proposed for measurement properties of health status questionnaires.

Authors:  Caroline B Terwee; Sandra D M Bot; Michael R de Boer; Daniëlle A W M van der Windt; Dirk L Knol; Joost Dekker; Lex M Bouter; Henrica C W de Vet
Journal:  J Clin Epidemiol       Date:  2006-08-24       Impact factor: 6.437

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 3.  Current treatment paradigms in the management of lymphatic malformations.

Authors:  John P Renton; Richard J H Smith
Journal:  Laryngoscope       Date:  2011-01       Impact factor: 3.325

4.  Management of lymphatic malformations and macroglossia: results of a national treatment survey.

Authors:  David C Bloom; Jonathan A Perkins; Scott C Manning
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2009-06-09       Impact factor: 1.675

5.  Cystic hygroma of the head and neck--a long-term follow-up of 44 cases.

Authors:  B Charabi; P Bretlau; M Bille; M Holmelund
Journal:  Acta Otolaryngol Suppl       Date:  2000

Review 6.  Cystic hygroma-lymphangioma: a rare and still unclear entity.

Authors:  T L Kennedy
Journal:  Laryngoscope       Date:  1989-10       Impact factor: 3.325

Review 7.  Treatment guidelines of lymphatic malformations of the head and neck.

Authors:  Qin Zhou; Jia Wei Zheng; Hua Ming Mai; Quan Feng Luo; Xin Dong Fan; Li Xin Su; Yan An Wang; Zhong Ping Qin
Journal:  Oral Oncol       Date:  2011-09-08       Impact factor: 5.337

Review 8.  Lymphatic malformations: review of current treatment.

Authors:  Jonathan A Perkins; Scott C Manning; Richard M Tempero; Michael J Cunningham; Joseph L Edmonds; Fredric A Hoffer; Mark A Egbert
Journal:  Otolaryngol Head Neck Surg       Date:  2010-06       Impact factor: 3.497

9.  Lymphatic malformations of the head and neck. A proposal for staging.

Authors:  L M de Serres; K C Sie; M A Richardson
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1995-05

10.  Lymphatic malformations of the head and neck: introduction of a disease score for children, Cologne Disease Score (CDS).

Authors:  Claus Wittekindt; Olaf Michel; Michael Streppel; Bernhard Roth; Gero Quante; Dirk Beutner; Orlando Guntinas-Lichius
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2006-02-07       Impact factor: 1.675

View more
  4 in total

1.  Volumetric Assessment of Pediatric Vascular Malformations Using a Rapid, Hand-Held Three-Dimensional Imaging System.

Authors:  Ethan J Speir; C Matthew Hawkins; Michael J Weiler; Michael Briones; Rachel Swerdlin; Solomon Park; J Brandon Dixon
Journal:  J Digit Imaging       Date:  2019-04       Impact factor: 4.056

Review 2.  New Frontiers in Our Understanding of Lymphatic Malformations of the Head and Neck: Natural History and Basic Research.

Authors:  Jonathan A Perkins
Journal:  Otolaryngol Clin North Am       Date:  2018-02       Impact factor: 3.346

Review 3.  Pediatric lymphatic malformations: evolving understanding and therapeutic options.

Authors:  Ann M Defnet; Naina Bagrodia; Sonia L Hernandez; Natalie Gwilliam; Jessica J Kandel
Journal:  Pediatr Surg Int       Date:  2016-01-27       Impact factor: 1.827

4.  Outcome measurement instruments for peripheral vascular malformations and an assessment of the measurement properties: a systematic review.

Authors:  Sophie E R Horbach; Amber P M Rongen; Roy G Elbers; Chantal M A M van der Horst; Cecilia A C Prinsen; Phyllis I Spuls
Journal:  Qual Life Res       Date:  2019-09-23       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.